Search Results - "Nidorf, Stefan Mark"
-
1
Viewing atherosclerosis through a crystal lens: How the evolving structure of cholesterol crystals in atherosclerotic plaque alters its stability
Published in Journal of clinical lipidology (01-09-2020)“…Reducing the residual risk of cardiovascular (CV) events in patients with atherosclerosis continues to be a challenge. Thus, understanding how cholesterol…”
Get full text
Journal Article -
2
Editorial: Role of colchicine in atherosclerosis
Published in Frontiers in cardiovascular medicine (21-11-2024)Get full text
Journal Article -
3
The challenge of reducing residual cardiovascular risk in patients with chronic kidney disease
Published in European heart journal (07-12-2022)Get full text
Journal Article -
4
Seeing Colchicine in a New Light: Repurposing Low-dose Colchicine for Secondary Prevention of Cardiovascular Disease
Published in Clinical therapeutics (01-11-2023)“…This review presents a modern perspective on the cardiovascular re-purposing of colchicine, the oldest drug in the pharmacopeia other than aspirin that is…”
Get full text
Journal Article -
5
Insights into the evolving nature of atherosclerosis from surveillance of the aortic landscape in-vivo
Published in Atherosclerosis (01-07-2022)Get full text
Journal Article -
6
Editorial commentary: Embracing colchicine as a new cornerstone therapy for coronary disease
Published in Trends in cardiovascular medicine (01-11-2021)“…By demonstrating the CV benefits of colchicine in both chronic and recently unstable coronary disease, these trials have laid the foundation for it to be…”
Get full text
Journal Article -
7
Why Colchicine Should Be Considered for Secondary Prevention of Atherosclerosis: An Overview
Published in Clinical therapeutics (01-01-2019)“…Colchicine is a widely available, inexpensive drug with a range of antiinflammatory properties that may make it suitable for the secondary prevention of…”
Get full text
Journal Article -
8
Low-dose colchicine for atherosclerosis: long-term safety
Published in European heart journal (13-05-2024)“…Low-dose colchicine (0.5 mg daily) is now FDA-approved for secondary prevention in patients with coronary disease and will be increasingly prescribed in…”
Get full text
Journal Article -
9
Prognostic significance of an early rise to peak creatine kinase after acute myocardial infarction
Published in The American journal of cardiology (01-06-1988)“…Because an early rise to peak creatine kinase (CK) is regarded as a noninvasive marker of early coronary reperfusion, the short- and long-term significance of…”
Get full text
Journal Article -
10
The creatine kinase ratio: A useful means of detecting early peaking of the creatine kinase curve after acute myocardial infarction
Published in The American journal of cardiology (01-11-1988)“…Although early peaking of the creatine kinase (CK) curve has been found to be a marker of both early coronary reperfusion 1–7 and late prognosis 8,9 after…”
Get full text
Journal Article